Similarly, the panel composed of serum miR-210, miR-183, miR-182, miR-126, and CEA has higher diagnostic potential for all-stage and early-stage NSCLC (AUC, sensitivity, specificity: 0.97, 81%, 100%, and 0.98, 89%, 93%, respectively) than CEA alone [103]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.